Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S, Saeed BQ, Temirgalieva E, Yumashev AV, El-Esawi MA, Navashenaq JG, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, Jadidi-Niaragh F, Adigozalou J, Ahmadi M, Roshangar L. Tahmasebi S, et al. Among authors: yumashev av. Life Sci. 2021 Jul 1;276:119437. doi: 10.1016/j.lfs.2021.119437. Epub 2021 Mar 28. Life Sci. 2021. PMID: 33789145 Free PMC article.
The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy.
Shabgah AG, Salmaninejad A, Thangavelu L, Alexander M, Yumashev AV, Goleij P, Hedayati-Moghadam M, Mohammadi H, Ahmadi M, Navashenaq JG. Shabgah AG, et al. Among authors: yumashev av. Prog Biophys Mol Biol. 2021 May;161:17-26. doi: 10.1016/j.pbiomolbio.2020.11.006. Epub 2020 Nov 28. Prog Biophys Mol Biol. 2021. PMID: 33259833 Review.
Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies.
Vakili-Samiani S, Turki Jalil A, Abdelbasset WK, Yumashev AV, Karpisheh V, Jalali P, Adibfar S, Ahmadi M, Hosseinpour Feizi AA, Jadidi-Niaragh F. Vakili-Samiani S, et al. Among authors: yumashev av. DNA Repair (Amst). 2021 Nov;107:103203. doi: 10.1016/j.dnarep.2021.103203. Epub 2021 Aug 8. DNA Repair (Amst). 2021. PMID: 34390915 Review.
CAR T cells in solid tumors: challenges and opportunities.
Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. Marofi F, et al. Among authors: yumashev av. Stem Cell Res Ther. 2021 Jan 25;12(1):81. doi: 10.1186/s13287-020-02128-1. Stem Cell Res Ther. 2021. PMID: 33494834 Free PMC article. Review.
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Motavalli Khiavi F. Marofi F, et al. Among authors: yumashev av. Stem Cell Res Ther. 2021 Mar 29;12(1):217. doi: 10.1186/s13287-021-02283-z. Stem Cell Res Ther. 2021. PMID: 33781320 Free PMC article. Review.
CAR-NK cell in cancer immunotherapy; A promising frontier.
Marofi F, Abdul-Rasheed OF, Rahman HS, Budi HS, Jalil AT, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Chartrand MS, Ahmadi M, Cid-Arreguid A, Jarahian M. Marofi F, et al. Among authors: yumashev av. Cancer Sci. 2021 Sep;112(9):3427-3436. doi: 10.1111/cas.14993. Epub 2021 Jul 7. Cancer Sci. 2021. PMID: 34050690 Free PMC article. Review.
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Khiavi FM. Marofi F, et al. Among authors: yumashev av. Stem Cell Res Ther. 2021 Aug 6;12(1):443. doi: 10.1186/s13287-021-02523-2. Stem Cell Res Ther. 2021. PMID: 34362452 Free PMC article. No abstract available.
26 results